ストックスクリーナーアプリを入手
18.77
0.79%
-0.15
アフターアワーズ：
18.60
-0.17
-0.91%
前日終値:
$18.92
開ける：
$19.1
24時間の取引高:
224.13K
Relative Volume:
0.65
時価総額：
$706.53M
収益：
$89.06M
当期純損益:
$-53.41M
株価収益率:
-12.85
EPS:
-1.4612
ネットキャッシュフロー:
$-42.48M
1週間 パフォーマンス:
-0.64%
1か月 パフォーマンス:
-0.95%
6か月 パフォーマンス:
+66.11%
1年 パフォーマンス:
-6.89%
1日の値動き範囲:
$18.60
$20.16
1週間の範囲:
$18.39
$20.16
52週間の値動き範囲:
$10.01
$24.33
Ceribell Inc Stock (CBLL) Company Profile
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
18.77 | 712.17M | 89.06M | -53.41M | -42.48M | -1.4612 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | 開始されました | Raymond James | Strong Buy |
| 2025-06-24 | 開始されました | BTIG Research | Buy |
| 2025-04-04 | 開始されました | Ladenburg Thalmann | Buy |
| 2024-11-05 | 開始されました | BofA Securities | Buy |
| 2024-11-05 | 開始されました | Canaccord Genuity | Buy |
| 2024-11-05 | 開始されました | JP Morgan | Overweight |
| 2024-11-05 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | 開始されました | William Blair | Outperform |
すべてを表示
Ceribell Inc (CBLL) 最新ニュース
ETF Watch: What are the risks of holding CeriBell Inc2026 Volume Leaders & Safe Capital Growth Stock Tips - baoquankhu1.vn
Ceribell, Inc. (CBLL) reports Q4 loss, beats revenue estimates - MSN
CeriBell, Inc. (NASDAQ:CBLL) Short Interest Update - MarketBeat
CBLL PE Ratio & Valuation, Is CBLL Overvalued - Intellectia AI
Suma receives Ceribell, Inc. accolade for breakthrough neonatal care innovation - Traders Union
Ceribell’s Woo sells $202k in shares - Investing.com Nigeria
Foehr David, senior VP at Ceribell, sells $81k in CBLL stock - Investing.com Nigeria
CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium - Yahoo Finance
CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot - Yahoo Finance
CBLL wins FDA breakthrough status for AI-based LVO stroke detection - MSN
Robertson sells Ceribell (CBLL) shares worth $14,720 By Investing.com - Investing.com India
CeriBell (NASDAQ:CBLL) CEO Sells $680,550.00 in Stock - MarketBeat
CeriBell (NASDAQ:CBLL) Director Rebecca Robertson Sells 827 Shares - MarketBeat
David Foehr Sells 4,560 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Robertson sells Ceribell (CBLL) shares worth $14,720 - Investing.com Nigeria
Ceribell CEO Chao sells $680k in CBLL stock By Investing.com - Investing.com Canada
Ceribell CEO Chao sells $680k in CBLL stock - Investing.com India
Ceribell Insider Sold Shares Worth $680,564, According to a Recent SEC Filing - marketscreener.com
Director at Ceribell (CBLL) sells 827 shares via Rule 10b5-1 plan - Stock Titan
Ceribell Earnings Call Highlights Strong Growth, Rising Costs - TipRanks
Ceribell’s Woo sells $202k in shares By Investing.com - Investing.com Australia
CeriBell (NASDAQ:CBLL) CTO Sells $147,587.75 in Stock - MarketBeat
CBLL (NASDAQ: CBLL) affiliate Xingjuan Chao sells multiple blocks totaling 145,084 shares - Stock Titan
CBLL (NASDAQ: CBLL) Rule 144 notice; affiliate to sell 4,560 shares - Stock Titan
CeriBell, Inc. (NASDAQ:CBLL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord - Insider Monkey
CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 43% Potential Upside in the Innovative Medical Devices Sector - directorstalkinterviews.com
CBLL Should I Buy - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL) and Option Care Health (OPCH) - The Globe and Mail
Earnings Call Summary | Ceribell(CBLL.US) Q4 2025 Earnings Conference - 富途牛牛
CeriBell (CBLL) Revenue Growth To US$24.8m Tests Premium Valuation Narrative - simplywall.st
Top Ceribell Executives Quietly Unload Shares in Coordinated Insider Move - TipRanks
Insider Selling: CeriBell (NASDAQ:CBLL) VP Sells 569 Shares of Stock - MarketBeat
Insider Selling: CeriBell (NASDAQ:CBLL) CTO Sells 705 Shares of Stock - MarketBeat
CeriBell (NASDAQ:CBLL) VP David Foehr Sells 781 Shares - MarketBeat
Insider Selling: CeriBell (NASDAQ:CBLL) CFO Sells 808 Shares of Stock - MarketBeat
[Form 4] Ceribell, Inc. Insider Trading Activity - Stock Titan
Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating - TipRanks
CeriBell (NASDAQ:CBLL) Shares Gap DownTime to Sell? - MarketBeat
Ceribell Inc. debuts AI-enabled neonatal EEG at NEO Pediatrix Conference - Traders Union
CeriBell revenue up 34% to USD 24.8M in Q4 2025 - Medical Buyer
CeriBell Q4 Revenue Rises 34%; Projects Revenue Growth Of 25%-29% For FY'26 - Nasdaq
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
CeriBell (CBLL) Q4 2025 Earnings Call Transcript - The Globe and Mail
Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating - TipRanks
CeriBell Q4 Earnings Call Highlights - Yahoo Finance
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates - Nasdaq
CeriBell, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
CBLLCeriBell, Inc. Latest Stock News & Market Updates - Stock Titan
Ceribell Inc (NASDAQ:CBLL) Reports Strong Q4 Revenue Beat and Provides 2026 Outlook - ChartMill
Ceribell Inc (CBLL) 財務データ
収益
当期純利益
現金流量
EPS
1.53%
大文字化:
|
ボリューム (24 時間):